-
SFDA issues the No.149 announcement of drug administrative protectionThe State Food and Drug Administration (SFDA) issued the No.149 Drug Administrative Protection Announcement on June 23, 2011, declaring the revocation of drug administrative protection for Ortho-McNei2011/6/28
-
Drug shortages have tripled during the last six yearsThe Baltimore Sun: Many Drugs In Short Supply At Hospitals, Pharmacies The drugs are among hundreds that have been in short supply at the nation's hospitals, and more recently, community pharmacies.2011/6/28
-
Endo recalls two lots of Endocet TabletsEndo Pharmaceuticals (Nasdaq: ENDP) today issued a voluntary nationwide consumer level recall of Endocet® (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg 100 count bottles, NDC 60951-712-70,2011/6/28
-
GlaxoSmithKline to Pay Settlement over Substandard Manufacturing ProcessesGlaxoSmithKline has agreed to pay $40.75m to 37 states and the District of Columbia in a settlement over substandard drug manufacturing processes. The settlement, announced by the company and Attor2011/6/27
-
Supreme Court sides with drug makers in two decisionsOne would shield pharmaceutical companies from most lawsuits filed by people injured by taking generic drugs. The other strikes down a Vermont law that banned some commercial uses — "data mining" — of2011/6/27
-
SFDA Deputy Commissioner Wu Zhen meets Director-General of Public Health of the Netherlands Ministry of Health, Welfare and SportOn June 21, 2011, Wu Zhen, Deputy Commissioner of the State Food and Drug Administration (SFDA), met with the visiting Paul Huijts, Director-General of Public Health of the Ministry of Health, Welfare2011/6/24
-
Australia to Subsidise 13 New DrugsMore than 400,000 Australians will benefit from 13 subsidised medicines from September, including patients suffering from multiple sclerosis, cystic fibrosis and various forms of cancer. Australia'2011/6/24
-
IPEC Federation statement on Taiwan Phthalate Contamination IncidentIPEC Federation: Taiwan Phthalate Contamination Incident Impact on Safety of Excipients June 15, 2011 Recent events in Taiwan have raised the possibility of Di-Ethyl Hexyl Phthalate (DEHP) and2011/6/23
-
Australia to Subsidise 13 New DrugsMore than 400,000 Australians will benefit from 13 subsidised medicines from September, including patients suffering from multiple sclerosis, cystic fibrosis and various forms of cancer. Australia'2011/6/23
-
Scientists Develop New Cystic Fibrosis DrugAn international team of scientists has developed a new drug for cystic fibrosis sufferers. VX-770 targets people with the 'celtic gene', a genetic mutation particularly common in patients with the2011/6/23